SFAM
GILD icon

Sawyer Falduto Asset Management’s Gilead Sciences GILD Stock Holding History

Sawyer Falduto Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.8K Buy
410
+269
+191% +$35.4K 0.04% 97
2026
Q1 		$19.7K Hold
141
– – 0.02% 144
2025
Q4 		$17.3K Buy
+141
New +$17.1K 0.02% 148

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sawyer Falduto Asset Management's GILD Position: Q2 2026 in Review

Sawyer Falduto Asset Management increased its Gilead Sciences (GILD) stake by 191% in Q2 2026, buying an estimated $35.4K and bringing the position to 410 shares worth $51.8K. The position accounts for 0.04% of the portfolio, ranked #97.

Sawyer Falduto Asset Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sawyer Falduto Asset Management held 410 shares of Gilead Sciences worth $51.8K as of Q2 2026.
  • Sawyer Falduto Asset Management bought 269 Gilead Sciences shares in Q2 2026, an estimated $35.4K.
  • Gilead Sciences made up 0.04% of Sawyer Falduto Asset Management's portfolio in Q2 2026, its #97 holding.
  • Sawyer Falduto Asset Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sawyer Falduto Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.